Grufity logoGrufity logo
StocksFundsScreenerSectorsWatchlists
MET

MET - MetLife Inc Stock Price, Fair Value and News

72.44USD+0.05 (+0.07%)Delayed as of 18 Mar 2024, 02:53 pm ET

Market Summary

MET
USD72.44+0.05
Delayedas of 18 Mar 2024, 02:53 pm
0.07%

MET Alerts

  • 1 major insider sales recently.
  • Big fall in earnings (Y/Y)

MET Stock Price

View Fullscreen

MET RSI Chart

MET Valuation

Market Cap

52.3B

Price/Earnings (Trailing)

33.17

Price/Sales (Trailing)

0.78

EV/EBITDA

10.06

Price/Free Cashflow

3.81

MET Price/Sales (Trailing)

MET Profitability

EBT Margin

3.23%

Return on Equity

5.23%

Return on Assets

0.23%

Free Cashflow Yield

26.22%

MET Fundamentals

MET Revenue

Revenue (TTM)

66.9B

Rev. Growth (Yr)

21.91%

Rev. Growth (Qtr)

19.93%

MET Earnings

Earnings (TTM)

1.6B

Earnings Growth (Yr)

-61.53%

Earnings Growth (Qtr)

24.13%

Breaking Down MET Revenue

52 Week Range

48.9572.67
(Low)(High)

Last 7 days

1.9%

Last 30 days

-0.1%

Last 90 days

9.9%

Trailing 12 Months

-3.7%

How does MET drawdown profile look like?

MET Financial Health

Debt/Equity

0.62

Debt/Cashflow

0.73

MET Investor Care

Dividend Yield

2.85%

Dividend/Share (TTM)

2.06

Buy Backs (1Y)

6.63%

Diluted EPS (TTM)

1.83

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202368.8B69.9B63.5B66.9B
202268.5B65.5B70.9B68.8B
202165.1B69.5B70.4B68.7B
202071.6B68.2B65.6B67.8B
201969.4B65.8B68.1B69.6B
201862.1B68.0B68.1B67.9B
201759.5B58.8B59.1B62.3B
201661.2B63.0B62.9B60.6B
201572.5B68.4B65.5B61.3B
201467.6B70.1B72.7B73.3B
201369.9B67.2B67.1B68.2B
201270.3B71.5B67.6B68.2B
201155.1B58.1B66.2B70.2B
201043.9B49.8B51.9B52.2B
200949.6B45.8B42.7B41.1B
2008048.4B49.7B51.0B
200700047.2B

Tracking the Latest Insider Buys and Sells of MetLife Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Mar 13, 2024
tadros ramy
sold
-289,479
71.9025
-4,026
president, u.s. business
Mar 01, 2024
mccallion john d.
sold (taxes)
-360,086
69.73
-5,164
evp & chief financial officer
Mar 01, 2024
debel marlene
sold (taxes)
-191,130
69.73
-2,741
evp & chief risk officer
Mar 01, 2024
khalaf michel
sold (taxes)
-1,142,250
69.73
-16,381
president & ceo
Mar 01, 2024
schock tamara
sold (taxes)
-87,511
69.73
-1,255
evp & chief accounting officer
Mar 01, 2024
pappas bill
sold (taxes)
-309,113
69.73
-4,433
evp, global tech. & ops.
Mar 01, 2024
podlogar susan m
sold (taxes)
-132,975
69.73
-1,907
evp & chief hr officer
Mar 01, 2024
tadros ramy
sold (taxes)
-336,168
69.73
-4,821
president, u.s. business
Feb 27, 2024
schock tamara
acquired
-
-
10,108
evp & chief accounting officer
Feb 27, 2024
mccallion john d.
acquired
-
-
82,760
evp & chief financial officer

1–10 of 50

Which funds bought or sold MET recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Mar 14, 2024
Leo Wealth, LLC
new
-
258,094
258,094
0.03%
Mar 14, 2024
ABLES, IANNONE, MOORE & ASSOCIATES, INC.
new
-
926
926
-%
Mar 12, 2024
Spartan Planning & Wealth Management
added
330
43,887
56,343
0.06%
Mar 11, 2024
VANGUARD GROUP INC
reduced
-1.06
146,602,000
3,812,270,000
0.08%
Mar 08, 2024
ICA Group Wealth Management, LLC
new
-
47,150
47,150
0.01%
Mar 08, 2024
TRUST CO OF VERMONT
reduced
-1.22
6,336
171,475
0.01%
Mar 06, 2024
SageView Advisory Group, LLC
added
3.5
172,089
1,215,280
0.05%
Mar 04, 2024
RICHARDSON FINANCIAL SERVICES INC.
new
-
213,997
213,997
0.19%
Mar 04, 2024
Fortis Group Advisors, LLC
added
100
6,935
13,226
-%
Mar 04, 2024
TUCKER ASSET MANAGEMENT LLC
reduced
-23.21
-7,106
29,759
0.01%

1–10 of 46

Are Funds Buying or Selling MET?

Are funds buying MET calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own MET
No. of Funds

Unveiling MetLife Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 15, 2024
board of directors of metlife inc
16.2%
116,905,555
SC 13D/A
Feb 13, 2024
dodge & cox
7.2%
53,443,191
SC 13G/A
Feb 13, 2024
vanguard group inc
7.79%
57,648,051
SC 13G/A
Jan 26, 2024
blackrock inc.
7.1%
52,733,080
SC 13G/A
Nov 02, 2023
board of directors of metlife inc
16.0%
118,254,445
SC 13D/A
Aug 04, 2023
board of directors of metlife inc
16.0%
120,043,226
SC 13D/A
May 04, 2023
board of directors of metlife inc
15.9%
121,521,424
SC 13D/A
Feb 23, 2023
board of directors of metlife inc
15.9%
122,923,807
SC 13D/A
Feb 14, 2023
dodge & cox
6.8%
53,583,210
SC 13G/A
Feb 09, 2023
vanguard group inc
7.08%
55,519,588
SC 13G/A

Recent SEC filings of MetLife Inc

View All Filings
Date Filed Form Type Document
Mar 15, 2024
144
Notice of Insider Sale Intent
Mar 15, 2024
144
Notice of Insider Sale Intent
Mar 15, 2024
144
Notice of Insider Sale Intent
Mar 15, 2024
144
Notice of Insider Sale Intent
Mar 14, 2024
4
Insider Trading
Mar 13, 2024
144
Notice of Insider Sale Intent
Mar 12, 2024
144
Notice of Insider Sale Intent
Mar 12, 2024
8-K
Current Report
Mar 07, 2024
8-K
Current Report
Mar 05, 2024
4
Insider Trading

What is the Fair Value of MET?

Loading...
Disclaimer: Conduct thorough research and seek guidance from a certified financial advisor prior to finalizing any investment choices.

Peers (Alternatives to MetLife Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
54.9B
10.1B
1.88% 23.00%
56.57
5.45
17.79% -12.97%
51.9B
46.8B
3.76% 14.99%
14.26
1.11
-14.05% -64.38%
50.6B
41.4B
11.23% 17.09%
16.92
1.22
12.15% 5.24%
48.7B
18.7B
-4.06% 14.27%
10.45
2.6
-2.30% 5.45%
34.4B
13.6B
10.84% 34.09%
7.74
2.52
41.83% 201.02%
34.0B
1.4B
-2.02% 3200.44%
-181.05
23.64
-25.27% -3.53%
11.1B
7.8B
3.88% -7.53%
13.01
1.42
11.18% -5.12%
MID-CAP
10.0B
12.4B
7.43% 14.77%
7.77
0.81
3.35% -8.77%
9.4B
11.1B
5.52% 30.93%
14.66
0.85
9.21% 132.28%
4.6B
11.6B
-1.55% -17.34%
-6.11
0.39
-38.09% -155.38%
4.4B
2.8B
-0.25% 16.81%
21.1
1.57
100.59% -89.04%
SMALL-CAP
1.8B
1.2B
11.58% -9.43%
-19.55
1.45
24.25% -115.79%
966.9M
306.9M
8.27% -6.39%
15.57
3.15
4.11% 11.70%
679.7M
269.0M
-0.25% -2.80%
151.05
2.53
-46.68% -99.14%
55.3M
185.3M
-7.28% 1.59%
17.82
0.3
-3.68% -1.30%

MetLife Inc News

Latest updates
MarketBeat • 6 hours ago
MarketWatch • 15 Mar 2024 • 09:52 pm
InvestorsObserver • 15 Mar 2024 • 07:12 pm
MarketBeat • 15 Mar 2024 • 04:59 am
MarketWatch • 14 Mar 2024 • 09:52 pm
Investing.com • 14 Mar 2024 • 09:38 pm
MarketWatch • 13 Mar 2024 • 09:51 pm

MetLife Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Revenue19.9%19,02815,86616,62315,38815,60822,28315,47415,40517,70516,90518,52415,56219,41816,01514,09918,31017,14318,67817,49716,30215,662
Operating Expenses3.5%3,3163,2043,1333,0574.002,9222,9082,95210.003,2842,8813,1503,4243,4702,9833,2733,6313,4433,3903,2253,395
EBITDA Margin307.3%0.05*0.01*0.02*0.03*0.05*0.09*0.11*0.15*0.13*0.11*0.10*0.04*---------
Interest Expenses51.0%311206289183314156285150308166287153312153290136317137362148321
Income Taxes738.5%32739.0022.00172-67.0024873.00296-34.004531,075-72.006.0021447.001,242-625601551359409
Earnings Before Taxes76.2%9415344302572,0261,4159881,9351,6982,0424,4872911649231975,643-37.002,7912,2971,7442,471
EBT Margin895.1%0.03*0.00*0.01*0.02*0.04*0.08*0.09*0.14*0.11*0.10*0.08*0.02*---------
Net Income24.1%60748940280.001,5781,1629101,6341,5041,5843,4073631587061454,4015932,1841,7411,3812,067
Net Income Margin-41.2%0.02*0.04*0.05*0.05*0.08*0.07*0.08*0.11*0.09*0.08*0.07*0.02*---------
Free Cashflow49.1%5,1823,4753,0382,0262,4614,3104,3932,0405,3403,5062,2541,496---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Assets5.4%687,584652,120677,279674,266663,072650,104662,893724,284759,708761,664773,253769,814795,146780,492767,583737,741740,463742,812732,167713,188687,538
    Cash Equivalents38.4%20,63914,91215,41718,45620,19522,20020,54823,48820,04718,95625,03719,63519,79524,40524,28924,09416,59819,45218,43514,50615,821
  Goodwill1.4%9,2369,1099,2619,3799,2979,0059,1519,5109,5359,6389,7689,94410,1129,3609,2459,1599,3089,2789,4089,4189,422
Liabilities5.0%657,331626,225646,787641,843632,947624,774625,526670,047691,959692,331703,830703,677720,329706,923691,643667,278674,081674,193668,121654,450634,580
  Short Term Borrowings-26.1%119161200168175183196323341346393302393351303298235142158289268
Shareholder's Equity17.0%30,01525,65830,49232,42329,88129,64034,00942,70350,01369,33369,42366,13774,81773,56975,94070,46366,38268,61964,04658,73852,958
  Retained Earnings0.5%40,14639,95839,92839,95740,33241,03241,10141,40641,19740,42639,31836,37331,82436,78236,56836,91933,07832,94831,20929,94428,926
  Additional Paid-In Capital0.1%33,69033,66633,63033,61733,61633,58933,54833,53133,51133,45733,44033,91033,81233,74433,72833,71132,68032,63932,60232,53532,474
Shares Outstanding-1.8%731744757769779787798815826845861878---------
Minority Interest0.4%238237231229244254266272267283285273259253247242238251235229217
Float---42,800---50,100---51,500---33,100---46,500--
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q4
Cashflow From Operations49.1%5,1823,4753,0382,0262,3014,3104,3932,0405,0913,5062,2541,4965,1533,7938461,8475,1814,1462,3872,0721,301
Cashflow From Investing119.4%576-2,972-6,346-1,504-197-4,1122,115-426-2,862-8,2801,009-1,054-2,162-6,679-1,391-8,337-7,093-5,351557-5,6995,358
Cashflow From Financing79.2%-176-848379-2,295-4,4681,743-9,0881,865-1,086-1,1081,632-564-6,9932,88568014,157-1,0092,3279342,316-3,332
  Dividend Payments-1.5%386392399389393400408397405413421408415419419404406413419405415
  Buy Backs8.5%8597926727805966741,1169401,1761,0151,11399957180.00-5002507857505001,200

MET Income Statement

2023-12-31
Consolidated Statements of Operations - USD ($)
$ in Millions
3 Months Ended12 Months Ended
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Revenues           
Premiums        $ 44,283$ 48,510$ 41,152
Universal life and investment-type product policy fees        5,1525,2255,244
Net investment income        19,90815,91621,395
Other revenues        2,5262,6302,619
Net investment gains (losses)        (2,824)(1,260)1,543
Net derivative gains (losses)        (2,140)(2,251)(3,257)
Total revenues$ 19,028$ 15,866$ 16,623$ 15,388$ 15,608$ 22,283$ 15,474$ 15,40566,90568,77068,696
Expenses           
Policyholder benefits and claims        44,59049,50743,118
Policyholder liability remeasurement (gains) losses        (45)114(172)
Market Risk Benefit Remeasurement (Gains) Losses        (994)(3,674)(1,237)
Interest credited to policyholder account balances        7,8603,8945,571
Policyholder dividends        622706880
Other expenses        12,71011,85912,018
Total expenses18,08715,33216,19315,13113,58220,86814,48613,47064,74362,40660,178
Income (loss) before provision for income tax        2,1626,3648,518
Provision for income tax expense (benefit)        5601,0621,642
Net income (loss)614495408851,5811,1679151,6391,6025,3026,876
Less: Net income (loss) attributable to noncontrolling interests76653555241821
Net income (loss) attributable to MetLife, Inc.607489402801,5781,1629101,6341,5785,2846,855
Less: Preferred stock dividends3367326629642963198185195
Preferred stock redemption premium        006
Net income (loss) available to MetLife, Inc.’s common shareholders$ 574$ 422$ 370$ 14$ 1,549$ 1,098$ 881$ 1,571$ 1,380$ 5,099$ 6,654
Net income (loss) available to MetLife, Inc.’s common shareholders per common share:           
Basic$ 0.78$ 0.56$ 0.48$ 0.02$ 1.98$ 1.38$ 1.09$ 1.91$ 1.82$ 6.35$ 7.71
Diluted$ 0.77$ 0.56$ 0.48$ 0.02$ 1.96$ 1.37$ 1.08$ 1.89$ 1.81$ 6.30$ 7.65

MET Balance Sheet

2023-12-31
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Investments:  
Fixed maturity securities available-for-sale, at estimated fair value (net of allowance for credit loss of $184 and $183, respectively); and amortized cost: $300,555 and $306,025, respectively$ 281,412$ 276,780
Equity securities, at estimated fair value7571,684
Contractholder-directed equity securities and fair value option securities, at estimated fair value10,3319,668
Mortgage loans (net of allowance for credit loss of $721 and $527, respectively)92,50683,763
Policy loans8,7888,874
Real estate and real estate joint ventures (includes $317 and $299, respectively, under the fair value option)13,33213,137
Other limited partnership interests14,76414,414
Short-term investments, principally at estimated fair value6,0454,935
Other invested assets (net of allowance for credit loss of $23 and $26, respectively; includes $1,993 and $1,926, respectively, of leveraged and direct financing leases; $333 and $326, respectively, relating to variable interest entities)18,20220,038
Total investments446,137433,293
Cash and cash equivalents, principally at estimated fair value20,63920,195
Accrued investment income3,5893,446
Premiums, reinsurance and other receivables28,97117,364
Market risk benefits, at estimated fair value286280
Deferred policy acquisition costs and value of business acquired20,15119,653
Current income tax recoverable19042
Deferred income tax asset2,6122,439
Goodwill9,2369,297
Other assets11,13911,025
Separate account assets144,634146,038
Total assets687,584663,072
Liabilities  
Future policy benefits196,406187,222
Policyholder account balances219,269210,597
Market risk benefits, at estimated fair value3,1793,763
Other policy-related balances19,73618,424
Policyholder dividends payable386387
Payables for collateral under securities loaned and other transactions17,52420,937
Short-term debt119175
Long-term debt15,54814,647
Collateral financing arrangement637716
Junior subordinated debt securities3,1613,158
Deferred income tax liability927950
Other liabilities35,80525,933
Separate account liabilities144,634146,038
Total liabilities657,331632,947
Contingencies, Commitments and Guarantees (Note 24)
MetLife, Inc.’s stockholders’ equity:  
Preferred stock, par value $0.01 per share; $3,905 aggregate liquidation preference00
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,191,823,651 and 1,189,831,471 shares issued, respectively; 730,821,111 and 779,098,414 shares outstanding, respectively1212
Additional paid-in capital33,69033,616
Retained earnings40,14640,332
Treasury stock, at cost; 461,002,540 and 410,733,057 shares, respectively(24,591)(21,458)
Accumulated other comprehensive income (loss)(19,242)(22,621)
Total MetLife, Inc.’s stockholders’ equity30,01529,881
Noncontrolling interests238244
Total equity30,25330,125
Total liabilities and equity$ 687,584$ 663,072
MET
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
 CEO
 WEBSITEwww.metlife.com
 EMPLOYEES45000

MetLife Inc Frequently Asked Questions


What is the ticker symbol for MetLife Inc? What does MET stand for in stocks?

MET is the stock ticker symbol of MetLife Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of MetLife Inc (MET)?

As of Fri Mar 15 2024, market cap of MetLife Inc is 52.34 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MET stock?

You can check MET's fair value in chart for subscribers.

What is the fair value of MET stock?

You can check MET's fair value in chart for subscribers. The fair value of MetLife Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of MetLife Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for MET so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is MetLife Inc a good stock to buy?

The fair value guage provides a quick view whether MET is over valued or under valued. Whether MetLife Inc is cheap or expensive depends on the assumptions which impact MetLife Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MET.

What is MetLife Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Mar 15 2024, MET's PE ratio (Price to Earnings) is 33.17 and Price to Sales (PS) ratio is 0.78. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MET PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on MetLife Inc's stock?

In the past 10 years, MetLife Inc has provided 0.075 (multiply by 100 for percentage) rate of return.